{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:37:24Z","timestamp":1760099844432},"reference-count":58,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T00:00:00Z","timestamp":1146182400000},"content-version":"vor","delay-in-days":8671,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunological Reviews"],"published-print":{"date-parts":[[1982,8]]},"DOI":"10.1111\/j.1600-065x.1982.tb00427.x","type":"journal-article","created":{"date-parts":[[2006,4,29]],"date-time":"2006-04-29T01:39:27Z","timestamp":1146274767000},"page":"55-78","source":"Crossref","is-referenced-by-count":41,"title":["Selective Effects of Adriamycin on Murine Host Defense Systems"],"prefix":"10.1111","volume":"65","author":[{"given":"M. Jane","family":"Ehrke","sequence":"first","affiliation":[]},{"given":"Stefan A.","family":"Cohen","sequence":"additional","affiliation":[]},{"given":"Enrico","family":"Mihich","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2006,4,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.124.2.141"},{"key":"e_1_2_1_3_1","first-page":"153","article-title":"Adriamycin (NSC\u2010i23127) Pharmacology","volume":"6","author":"Bachur N. R.","year":"1975","journal-title":"Cancer Chemother. Rep."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.124.3.363"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4049\/jimmunol.115.4.1007","article-title":"Mouse Effector Functions Involved in the Antibody\u2010dependent Cellular Cytotoxicity to Xenogeneic Erythrocytes","volume":"115","author":"Cohen S. A.","year":"1975","journal-title":"J. Immunol."},{"key":"e_1_2_1_6_1","first-page":"335","volume-title":"Advances in Enzyme Regulation","author":"Cohen S. A.","year":"1980"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1979.tb00266.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-010-9418-4_6"},{"key":"e_1_2_1_9_1","first-page":"521","article-title":"Selectivity of Inhibition by Anticancer Agents of Mouse Spleen Immune Effector Functions Involved in Responses to Sheep Erythrocytes","volume":"38","author":"Ehrke M. J.","year":"1978","journal-title":"Cancer Res."},{"key":"e_1_2_1_10_1","first-page":"273","article-title":"Generation of Cytotoxic Lymphocytes in Cultures of Spleen Cells from Tumor Bearing Mice: Modification by Adriamycin and Cyclophosphamide Treatment of the Mice","volume":"22","author":"Ehrke M. J.","year":"1981","journal-title":"Proc. Amer. Assoc. Cancer Res."},{"key":"e_1_2_1_11_1","first-page":"204","article-title":"Selective Imbalances of Cellular Immune Responses by Adriamycin","volume":"75","author":"Ehrke M. J.","year":"1980","journal-title":"Recent Results Cancer Res."},{"key":"e_1_2_1_12_1","first-page":"177","article-title":"Recognition and Destruction of Target Cells by Tumoricidal Macrophages","volume":"14","author":"Fidler I. J.","year":"1978","journal-title":"Isr. J. Med. Sci."},{"key":"e_1_2_1_13_1","first-page":"17","volume-title":"Glutathione: Metabolism and function","author":"Flohe L.","year":"1976"},{"key":"e_1_2_1_14_1","first-page":"435","article-title":"Virologic and Immunologic Properties and Response to Daunomycin and Adriamycin of a Non\u2010regressing Mouse Tumor Derived from MSV\u2010induced Sarcoma","volume":"21","author":"Giuliani F.","year":"1974","journal-title":"Biomedicine"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(77)80048-X"},{"key":"e_1_2_1_16_1","first-page":"298","article-title":"Selective Suppression of Humoral and Cellular Immunity with Cytosinearabinoside","volume":"32","author":"Griswold D. E.","year":"1972","journal-title":"Cancer Res."},{"key":"e_1_2_1_17_1","first-page":"3852","article-title":"Adriamycin\u2010activated Macrophages as Tumor Growth Inhibitors","volume":"41","author":"Haskill J. S.","year":"1981","journal-title":"Cancer Res."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(79)90038-9"},{"key":"e_1_2_1_19_1","first-page":"1161","article-title":"Suppression by Cytosine Arabinoside of Serum\u2010blocking Factors of Cell\u2010mediated Immunity to Syngeneic Transplants of Mouse Mammary Tumors","volume":"48","author":"Heppner G. H.","year":"1972","journal-title":"J. Nat. Cancer Inst."},{"key":"e_1_2_1_20_1","first-page":"305","volume-title":"Advances in Cancer Research","author":"Herberman R. B.","year":"1978"},{"key":"e_1_2_1_21_1","first-page":"681","volume-title":"Cancer Medicine","author":"Hersh E. M.","year":"1973"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-65678-1_28"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/08923978009026398"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/288597a0"},{"key":"e_1_2_1_25_1","article-title":"Effects of Prostaglandins on the Development of Cell\u2010mediated Immunity in Culture and on the Cytolytic Activity of In Vivo Generated Effector Cells","volume":"4","author":"Leung K. H.","year":"1981","journal-title":"Int. J. Immunopharm."},{"key":"e_1_2_1_26_1","first-page":"815","article-title":"In Vitro and In Vivo Cytotoxicity of Adriamycin and Daunomycin for Murine Macrophages","volume":"37","author":"Mantovani A.","year":"1977","journal-title":"Cancer Res."},{"key":"e_1_2_1_27_1","first-page":"139","volume-title":"Current Trends in Tumor Immunology","author":"Mantovani A.","year":"1979"},{"key":"e_1_2_1_28_1","first-page":"61","article-title":"Role of Host Defense Mechanisms in the Antitumor Activity of Adriamycin and Daunomycin in Mice","volume":"63","author":"Mantovani A.","year":"1979","journal-title":"J. Nat. Cancer Inst."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(76)90176-6"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(76)90175-4"},{"key":"e_1_2_1_31_1","first-page":"271","volume-title":"Tumor\u2010Associated Antigens and Their Specific Immune Responses","author":"Mantovani A.","year":"1979"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(73)90025-7"},{"key":"e_1_2_1_33_1","first-page":"90","volume-title":"Prediction of Response in Cancer Chemotherapy and Immunity","author":"Mihich E.","year":"1971"},{"key":"e_1_2_1_34_1","first-page":"275","article-title":"Immunosuppression in Cancer Therapeutics. Proceedings of the First International Symposium on Cancer and Transplantation","volume":"7","author":"Mihich E.","year":"1975","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_35_1","first-page":"113","volume-title":"Advances in Tumor Prevention. Detection and Characterization","author":"Mihich E.","year":"1978"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4049\/jimmunol.120.5.1497","article-title":"Characterization of Lymphocyte\u2010activating Factor (LAE) Produced by the Macrophage Cell Line, P388D. I. Enhancement of LAF Production by Activated T Lymphocytes","volume":"120","author":"Mizel S. B.","year":"1978","journal-title":"J. Immunol."},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.877547"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198009113031106"},{"key":"e_1_2_1_39_1","first-page":"2527","article-title":"The Differentiation of Cytotoxic T Cells In Vitro. I. Amplifying Factor(s) in the Primary Response is Lyt l+ Cell Dependent","volume":"122","author":"Okada M.","year":"1979","journal-title":"J. Immunol."},{"key":"e_1_2_1_40_1","first-page":"450","article-title":"Regulatory Role of Glutathione and Soluble Sutfhydryl Groups in the Toxicity of Adriamycin","volume":"215","author":"Olson R. D.","year":"1980","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_1_41_1","first-page":"130","article-title":"Immunosuppression by Adriamycin (AM) and Daunorubicin (DM)","volume":"16","author":"Orsini F.","year":"1975","journal-title":"Proc. Amer. Assoc. Cancer Res."},{"key":"e_1_2_1_42_1","first-page":"1719","article-title":"Increased Primary Cell Mediated Immunity in Culture Subsequent to Adriamycin or Daunorubicin Treatment of Spleen Donor Mice","volume":"37","author":"Orsini F.","year":"1977","journal-title":"Cancer Res."},{"key":"e_1_2_1_43_1","first-page":"4767","article-title":"Derivation of Human T\u2010Cell Leukemias","volume":"41","author":"Reinherz E. L.","year":"1981","journal-title":"Cancer Res."},{"key":"e_1_2_1_44_1","first-page":"4771","article-title":"Use of Monoclonal Antibodies as Diagnostic and Therapeutic Reagents in Acute Lymphoblastic Leukemia","volume":"41","author":"Ritz J.","year":"1981","journal-title":"Cancer Res"},{"key":"e_1_2_1_45_1","first-page":"14","volume-title":"Advances in Enzyme Regulation","author":"Rustum Y. M.","year":"1976"},{"key":"e_1_2_1_46_1","first-page":"7","article-title":"Reduced Sensitivity to \u201cAntigen\u2010specific\u201d Suppression Caused by Adriamycin (AM)","volume":"17","author":"Ryoyama K.","year":"1980","journal-title":"Abst. 4th Int. Congr. Immunol."},{"key":"e_1_2_1_47_1","first-page":"23","volume-title":"Proceedings of the EORTC Symposium on Immuno\u2010Pharmacologic Effects of Radiotherapy","author":"Ryoyama K.","year":"1981"},{"key":"e_1_2_1_48_1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.4049\/jimmunol.124.5.2329","article-title":"Effects of Adriamycin on the Activity of Mouse Natural Killer Cells","volume":"124","author":"Santoni A.","year":"1980","journal-title":"J. Immunol."},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.140.6.1534"},{"key":"e_1_2_1_50_1","first-page":"1837","article-title":"Adriamycin and Daunorubicin: A Comparison of Antitumor Activities and Tissue Uptake in Mice Following Immunosuppression","volume":"33","author":"Schwartz H. S.","year":"1973","journal-title":"Cancer Res"},{"key":"e_1_2_1_51_1","first-page":"107","article-title":"Cell Interactions; Determinants of Selective Toxicity of Adriamycin and Daunorubicin","volume":"6","author":"Schwartz H.","year":"1975","journal-title":"Cancer Chemotherapy Rep."},{"key":"e_1_2_1_52_1","first-page":"413","volume-title":"Drug Resistance and Selectivity: Biochemical and Cellular Basis","author":"Schwartz H. S.","year":"1973"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1979.tb47136.x"},{"key":"e_1_2_1_54_1","first-page":"3014","article-title":"Effects of Adriamycin and Cyclophosphamide Treatment on Induction of Macrophage Cytotoxic Function in Mice","volume":"39","author":"Stoychkov J. N.","year":"1979","journal-title":"Cancer Res."},{"key":"e_1_2_1_55_1","first-page":"3964","article-title":"Sensitivity to Chemotherapeutic and Immunomodulating Agents of Two Mouse Lymphomas and of a Macrophage Tumor","volume":"39","author":"Tarnowski G. S.","year":"1979","journal-title":"Cancer Res."},{"key":"e_1_2_1_56_1","first-page":"2748","article-title":"Modulation of the Cytotoxic Response Against Allogeneic Tumor Cells in Culture by Adriamycin","volume":"40","author":"Tomazic V.","year":"1980","journal-title":"Cancer Res."},{"key":"e_1_2_1_57_1","first-page":"3370","article-title":"Augmentation of the Development of Immune Responses of Mice Against Allogeneic Tumor Cells After Adriamycin Treatment","volume":"41","author":"Tomazic V.","year":"1981","journal-title":"Cancer Res."},{"key":"e_1_2_1_58_1","first-page":"1222","article-title":"A Characterization of Immunosuppressive Activity of Adriamycin and Daunomycin on Humoral Antibody Production and Tumor Allograft Rejection","volume":"36","author":"Vecchi A.","year":"1976","journal-title":"Cancer Res."},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(80)90187-8"}],"container-title":["Immunological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-065X.1982.tb00427.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-065X.1982.tb00427.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T13:47:22Z","timestamp":1699451242000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-065X.1982.tb00427.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,8]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1982,8]]}},"alternative-id":["10.1111\/j.1600-065X.1982.tb00427.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-065x.1982.tb00427.x","archive":["Portico"],"relation":{},"ISSN":["0105-2896","1600-065X"],"issn-type":[{"value":"0105-2896","type":"print"},{"value":"1600-065X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,8]]}}}